OPPI believes that it is imperative for the industry to build a quality culture in the country and provide medicines with global quality standards to the patients.
This is a critical component in any industry but especially in the pharmaceutical industry, where patient safety is paramount. Pharmaceutical industry participants as well as regulatory authorities have always prioritised Good Manufacturing Practices (GMP). The COVID-19 pandemic has highlighted the importance of high-quality products with a reliable supply chain. We are committed to the Hon’ble Prime Minister Shri Narendra Modi-ji’s clarion call of ‘Jai Vigyan and Jai Anusandhan’. As an association, our advocacy decisions, patient commitment and work are always keeping the country first and we embody the spirit of working for ‘Bharat Ke Liye’ driven with innovation to find solutions for unmet medical needs, collaboration with government stakeholders, and co-creation with partners coming together to address the nation’s healthcare challenges. Our member companies have been serving the country’s healthcare ecosystem since pre-independence and continue to remain committed to patient safety and providing quality care in the future as well. We remain committed to supporting the nation’s healthcare objectives, putting patients at the core of all decision making and collaborating with all stakeholders to find sustainable solutions to realize the collective vision of Health for All. OPPI has been an integral part of the healthcare journey of the country. The Organisation of Pharmaceutical Producers of India (OPPI) established in 1965, represents the research-based global pharmaceutical companies in India.
0 kommentar(er)
